Skip to content

Weight control in overweight / obese population: a real world prospective cohort follow-up study

Weight control in overweight / obese population: a real world prospective cohort follow-up study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006551
Enrollment
Unknown
Registered
2022-08-31
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

TCM Comprehensive intervention program group:The specific contents are as follows: Traditional Chinese medicine decoction: according to the syndrome differentiation and treatment of traditional Chines
Group not receiving comprehensive intervention plan of traditional Chinese Medicine:Including those who only received western medicine treatment (taking orlistat, metformin, liraglutide, smegliptide a

Sponsors

Hubei Provincial Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. diagnostic criteria (1) Overweight: 24.0kg/m2 = BMI = 27.9kg/m2; (2) Obesity: BMI = 28kg/m2; 2. inclusion criteria (1) Age: 10-65 years old, regardless of gender; (2) Recent body mass is stable and BMI = 24.0 kg/m2;; (3) Good compliance, willing to follow the follow-up principle; (4) Agree to sign the informed consent form; (5) Only those who meet all the above conditions can participate in this study.

Exclusion criteria

Exclusion criteria: . Exclusion criteria (1) Complicated with heart, liver, lung, kidney, brain, blood, neuropsychiatric system and other serious diseases; (2) Iatrogenic obesity (refers to obesity caused by drugs and treatment methods in the treatment of other diseases); (3) Pregnant or lactating women; (4) The researcher thinks it is not suitable to participate in this study; (5) If any of the above conditions is met, you cannot participate in this study.

Design outcomes

Primary

MeasureTime frame
Weight;

Secondary

MeasureTime frame
Incidence rate of obesity related complications, including metabolic syndrome, pre diabetes, type 2 diabetes, abnormal lipid metabolism, hypertension, nonalcoholic fatty liver (or metabolic related fatty liver disease), polycystic ovary syndrome, female infertility, male hypogonadism, obstructive sleep apnea syndrome, asthma and / or&;Waist and hip circumference improvement rate;

Countries

China

Contacts

Public ContactMingzhong Xiao

Hubei Provincial Hospital of traditional Chinese Medicine

309452513@qq.com18908640865

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026